๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Locally Advanced Head and Neck Squamous Cell Carcinoma
Clinical trial register · China

Locally Advanced Head and Neck Squamous Cell Carcinoma Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Changsha 3 Shanghai 3 Zhuhai 2 Guangzhou 2 Hangzhou 2
Narrow the registerReset
Recruitment status
Phase
Site location
Changsha3 Shanghai3 Zhuhai2 Guangzhou2 Hangzhou2
All 13 locations
Target enrolment
to

Locally Advanced Head and Neck Squamous Cell Carcinoma trials in China

12 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer
NCT07780877Head & Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
Fudan University
Phase 2
85
Changsha, Shanghai
2026-08
Recruiting
Sintilimab Plus Hypofractionated Radiotherapy Followed by Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07781072Locally Advanced Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
27
Hangzhou
2026-06-12
Not yet open
Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC
NCT07554768Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
Chen Chunyan
Phase 2
36
Guangzhou
2026-05-01
Recruiting
Comparison of Efficacy Between De-escalated Surgery and Standard Surgery After Neoadjuvant Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07369882Locally Advanced Head and Neck Squamous Cell Carcinoma
Qunxing Li,MD
Not applicable
60
Guangzhou
2026-01-12
Recruiting
Low-Dose Radiotherapy and Anti-PD-1 Immunotherapy as Neoadjuvant Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT07371234Locally Advanced Head and Neck Squamous Cell Carcinoma
Rui You
Phase 2
22
Guangdong
2025-12-15
Recruiting
Tirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell Carcinoma
NCT06470217Locally Advanced Head and Neck Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
116
Shanghai
2024-06-19
Recruiting
A Prospective Randomized Controlled Study of Immune Checkpoint Maintenance Therapy After Radiotherapy and Chemotherapy for Locally Advanced Head and Neck Tumors Based on Peripheral Blood CD8Tex Detection in Peripheral Blood
NCT06240689Locally Advanced Head and Neck Squamous Cell Carcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
104
Hangzhou
2024-01-25
Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
NCT06129864Locally Advanced Head and Neck Squamous Cell Carcinoma
AstraZeneca
Phase 3
1,145
Beijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Dongwan, Fuzhou
2023-12-14
Recruiting
De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC
NCT06572514Locally Advanced Head and Neck Squamous Cell Carcinoma
Ruijin Hospital
Phase 1/2
20
Shanghai
2023-10-17
Recruiting
TPExtreme Induced Chemotherapy Followed by Surgery and Radiotherapy in the Oral Carcinoma.
NCT05872880Oral Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma
Xiangya Hospital of Central South University
Observational
124
Changsha
2022-04-01
Active, closed
Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC
NCT04947241Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 1
20
Zhuhai
2020-12-15
Rows per page Showing 1–12 of 12
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/locally-advanced-head-and-neck-squamous-cell-carcinoma

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 12 of those studies listing the condition Locally Advanced Head and Neck Squamous Cell Carcinoma.

How many Locally Advanced Head and Neck Squamous Cell Carcinoma trials are recruiting in China?

9 of the 12 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Locally Advanced Head and Neck Squamous Cell Carcinoma), 12 studies
PhaseStudiesRecruitingShare
Phase 26450%
Phase 32216.7%
Not applicable118.3%
Observational118.3%
Phase 1108.3%
Phase 1/2118.3%

Most active sponsors

Lead sponsors with the most studies (Locally Advanced Head and Neck Squamous Cell Carcinoma)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine22
AstraZeneca11
Chen Chunyan10
Fifth Affiliated Hospital, Sun Yat-Sen University10
Fudan University10
Ming-Yuan Chen11
Qunxing Li,MD11
Rui You11
Ruijin Hospital11
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.